You are here

siRNA

Sirus Therapeutics announces positive signals from Phase I siRNA trial

Clinical Trials Arena

Tue, 12/10/24 - 11:11 am

Sirus Therapeutics

clinical terials

myocardial infarction

ischemic stroke

Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases

BioSpace

Wed, 10/9/24 - 09:46 am

Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion

Pharmaceutical Technology

Sun, 07/21/24 - 11:04 pm

Rona Therapeutics

AstraZeneca & Aptamer partner to bolster targeted siRNA therapies

Clinical Trials Arena

Mon, 07/8/24 - 11:33 am

Silence breaks down phase 1 data on blood disorder prospect, sharing glimpse at pitch for competitive niche

Fierce Biotech

Thu, 06/27/24 - 10:11 pm

Silence Therapeutics

polycythemia vera

New ‘One-And-Done’ Vaccine Method Could Protect Infants—From Covid, Flu—With Just A Single Shot, Study Suggests

Forbes

Mon, 04/15/24 - 09:35 pm

universal vaccines

Boehringer bets $2B in biobucks to unlock siRNA targets for NASH treatments

Fierce Biotech

Wed, 01/3/24 - 09:40 am

Boehringer Ingelheim

AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year

Pharmaphorum

Mon, 11/13/23 - 10:03 am

cardiovascular disease

Agios and Alnylam sign agreement for siRNA candidate

Pharmaceutical Business Review

Fri, 08/4/23 - 12:09 pm

Agios Pharmaceuticals

polycythemia vera

Aligos culls another hepatitis B asset, citing inconclusive efficacy data

Fierce Biotech

Fri, 08/4/23 - 10:12 am

Algios Therapeutics

Novartis buys a preclinical biotech and its RNA drug technology

BioPharma Dive

Mon, 07/17/23 - 07:07 pm

Medicxi backs siRNA-focused Aldena Therapeutics with $30M

Endpoints

Thu, 03/16/23 - 09:32 am

Aldena Therapeutics

Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks

Endpoints

Mon, 07/25/22 - 10:37 am

Rona Therapeutics

With Alzheimer's in its sights, Alnylam shares data on getting siRNA to targets beyond the liver

Fierce Pharma

Tue, 06/7/22 - 09:59 am

Alzheimer's disease

drug development

Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics

Pharmaceutical Business Review

Mon, 10/18/21 - 11:06 am

Silence Therapeutics

Hansoh Pharmaceutical

drug development

Novartis looks to manufacturing investment to drive down cost of siRNA drug

Biopharma Reporter

Mon, 08/9/21 - 11:01 am

drug manufacturing

Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics

Reuters

Wed, 03/25/20 - 10:34 am

Silence Therapeutics

drug development

cardiovascular disease

respiratory disease

metabolic disorders

Alnylam, Vir team up to develop siRNAs to tackle COVID-19

Fierce Biotech

Wed, 03/4/20 - 10:52 am

Vir Biotechnology

Sylentis' dry eye drug misses primary goals in phase 3

Fierce Biotech

Thu, 01/31/19 - 11:55 pm

dry eye disease

clinical trials

Alnylam Snaps Up Merck’s Sirna Therapeutics

Wall St Cheat Sheet

Mon, 01/13/14 - 02:51 pm

Pages